All In Biotech

NDA 018883 · Fresenius Medcl

Delflex W/ Dextrose 2.5% Low Magnesium In Plastic Container

Calcium Chloride, Dextrose, Magnesium Chloride, Sodium Chloride, Sodium Lactate · Intraperitoneal

Last checked: Nov 20, 2026Latest source record: Jan 26, 2021 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1984

Nov 30, 1984

Approved uses

1

Original approval plus efficacy supplements

Registered trials

9,299

2,122 Phase 3, 968 recruiting

FAERS reports

8,955

4,867 serious, 685 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Oct 30, 2026.

1. INDICATIONS AND USAGE DELFLEX® is indicated in the treatment of chronic kidney failure in patients being maintained on peritoneal dialysis. For treatment of chronic kidney failure. ( 1 )

Mechanism: DELFLEX peritoneal dialysis solutions are hypertonic peritoneal dialysis solutions containing dextrose, a monosaccharide, as the primary osmotic agent. An osmotic gradient must be created between the peritoneal membrane and the dialysis solution in order for ultrafiltration to occur. The hypertonic concentration of glucose in DELFLEX solutions exert an osmotic pressure across the peritoneal membrane resulting in transcapillary ultrafiltration. Like other peritoneal dialysis solutions, DELFLEX solutions contain electrolytes to facilitate the correction of acid-base and electrolyte...

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Nov 30, 1984 Original approval · Type 5 - New Formulation or New Manufacturer
6 products under this application
  • DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER · CALCIUM CHLORIDE 25.7MG/100ML; DEXTROSE 2.5GM/100ML; MAGNESIUM CHLORIDE 5.08MG/100ML; SODIUM CHLORIDE 538MG/100ML; SODIUM LACTATE 448MG/100ML · SOLUTION, INTRAPERITONEAL · Prescription · TE AT
  • DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER · CALCIUM CHLORIDE 25.7MG/100ML; DEXTROSE 4.25GM/100ML; MAGNESIUM CHLORIDE 15.2MG/100ML; SODIUM CHLORIDE 567MG/100ML; SODIUM LACTATE 392MG/100ML · SOLUTION, INTRAPERITONEAL · Prescription · TE AT
  • DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER · CALCIUM CHLORIDE 25.7MG/100ML; DEXTROSE 1.5GM/100ML; MAGNESIUM CHLORIDE 15.2MG/100ML; SODIUM CHLORIDE 567MG/100ML; SODIUM LACTATE 392MG/100ML · SOLUTION, INTRAPERITONEAL · Prescription · TE AT
  • DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER · CALCIUM CHLORIDE 25.7MG/100ML; DEXTROSE 4.25GM/100ML; MAGNESIUM CHLORIDE 5.08MG/100ML; SODIUM CHLORIDE 538MG/100ML; SODIUM LACTATE 448MG/100ML · SOLUTION, INTRAPERITONEAL · Prescription · TE AT
  • DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER · CALCIUM CHLORIDE 25.7MG/100ML; DEXTROSE 1.5GM/100ML; MAGNESIUM CHLORIDE 5.08MG/100ML; SODIUM CHLORIDE 538MG/100ML; SODIUM LACTATE 448MG/100ML · SOLUTION, INTRAPERITONEAL · Prescription · TE AT
  • DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER · CALCIUM CHLORIDE 25.7MG/100ML; DEXTROSE 2.5GM/100ML; MAGNESIUM CHLORIDE 15.2MG/100ML; SODIUM CHLORIDE 567MG/100ML; SODIUM LACTATE 392MG/100ML · SOLUTION, INTRAPERITONEAL · Prescription · TE AT

Clinical trials

Interventional ClinicalTrials.gov studies with "Chloride" as an intervention, any sponsor and status, largest first.

All 9,299 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • peritonitis1,624
  • peritonitis bacterial972
  • abdominal distension614
  • abdominal pain432
  • death343
  • malaise325
  • bloody peritoneal effluent288
  • dyspnoea286
  • pain278
  • infection274
  • fluid overload267
  • discomfort223

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
20081
20121
201318
2014127
2015456
2016721
2017764
20181,362
2019986
2020523
2021834
2022902
2023507
2024577
2025705
2026471

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 4,091 on PubMed

Sponsor: Fresenius Medcl · Also marketed as Delflex W/ Dextrose 4.25% In Plastic Container, Delflex W/ Dextrose 1.5% In Plastic Container, Delflex W/ Dextrose 4.25% Low Magnesium In Plastic Container, Delflex W/ Dextrose 1.5% Low Magnesium In Plastic Container, Delflex W/ Dextrose 2.5% In Plastic Container

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.